Calles-Sastre L, Mucientes-Rasilla J, San-Frutos Llorente L M, Royuela A, Garcia-Espantaleón Navas M, Herrero Gámiz S, Pérez-Medina T
Department of Obstetrics and Gynecology, Autonoma University of Madrid, Puerta de Hierro University Hospital, Spain.
Department of Nuclear Medicine, Autonoma University of Madrid, Puerta de Hierro University Hospital, Spain.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Jan-Feb;38(1):17-21. doi: 10.1016/j.remn.2018.08.001. Epub 2018 Oct 23.
18-Fluoro-2-deoxy-d-glucose positron emission tomography (F-FDG PET/CT) is considered to be the most accurate image method of detection of node or distant metastases in cervical cancer. Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) of F-FDG PET/CT are volumetric measurements of tumor cells with increased F-FDG uptake. The prognostic value of MTV and TLG in patients with advanced cervical cancer (ACC) were evaluated.
38 patients with ACC from one tertiary university hospital underwent F-FDG PET/CT between June 2009 and December 2015. Clinicopathologic factors and various PET parameters were analyzed to evaluate their relationship with recurrence-free survival (RFS) and overall survival (OS). These parameters were: maximum standardized uptake value (SUVmax), mean standardized uptake value (SUV mean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary tumor, of the pelvic nodes, of the paraaortic nodes and the metabolic volume of the metastases if any.
A total of 38 patients with ACC fulfilled the inclusion criteria. All of them underwent a F-FDG PET/CT before definitive chemoradiotherapy. In the univariate analyses higher tumor size, pelvic lymph node metastasis and both MTV and TLG showed a significant association with OS and with RFS (MTV HR=1.55, p=0.011 and TLG HR=1.43, p=0.017 for RFS and MTV HR=1.82, p=0.006 and TLG HR=1.67, p=0.007 for OS).
Pretreatment TLG sum and MTV sum seem to be independent prognostic factors for OS and RFS in patients with advanced cervical cancer treated with definitive chemoradiotherapy and they are better than the classic measurement of SUVmax.
18-氟-2-脱氧-D-葡萄糖正电子发射断层扫描(F-FDG PET/CT)被认为是检测宫颈癌淋巴结或远处转移最准确的影像方法。F-FDG PET/CT的代谢肿瘤体积(MTV)和总病变糖酵解(TLG)是对F-FDG摄取增加的肿瘤细胞进行的体积测量。评估MTV和TLG在晚期宫颈癌(ACC)患者中的预后价值。
2009年6月至2015年12月期间,一所三级大学医院的38例ACC患者接受了F-FDG PET/CT检查。分析临床病理因素和各种PET参数,以评估它们与无复发生存期(RFS)和总生存期(OS)的关系。这些参数包括:原发肿瘤、盆腔淋巴结、腹主动脉旁淋巴结的最大标准化摄取值(SUVmax)、平均标准化摄取值(SUV mean)、代谢肿瘤体积(MTV)和总病变糖酵解(TLG),以及如有转移灶的代谢体积。
共有38例ACC患者符合纳入标准。所有患者在确定性放化疗前均接受了F-FDG PET/CT检查。在单因素分析中,肿瘤体积较大、盆腔淋巴结转移以及MTV和TLG均与OS和RFS显著相关(RFS方面,MTV风险比[HR]=1.55,p=0.011,TLG HR=1.43,p=0.017;OS方面,MTV HR=1.82,p=0.006,TLG HR=1.67,p=0.007)。
预处理时的TLG总和及MTV总和似乎是接受确定性放化疗的晚期宫颈癌患者OS和RFS的独立预后因素,且它们优于经典的SUVmax测量值。